# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-25-008713
Filing Date
2025-02-28
Accepted
2025-02-28 16:45:07
Documents
4
Period of Report
2025-02-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm | PRE 14A | 228153
2 |  | formpre14a_001.jpg | GRAPHIC | 15987
3 |  | proxycard_001.jpg | GRAPHIC | 1108088
4 |  | proxycard_002.jpg | GRAPHIC | 1390054
| Complete submission text file | 0001493152-25-008713.txt |  | 3687812

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-27072 | Film No.: 25691331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)